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There are frequent anti-epileptic drugs used in management of epilepsy. 
Anti-epileptic drugs may have some complications on bone and vitamin D 
metabolism. This study aimed to comparison the bone metabolism disorder 
in epileptic children with healthy child in Zahedan, eastern Iran from Jul 
2014 to Jun 2015.
Materials & Methods
This case-control study was performed on bone metabolism disorder in 
epileptic children between 2014-2015. Forty epileptic children were 
enrolled based on accessibility scheme and 40 participants randomly 
selected for control group from those referred to the pediatric ward and 
clinic of Ali ebn Abi Talib Hospital and Ali Asghar Clinic in Zahedan City, 
Sistan & Baluchestan Province, eastern Iran. Blood samples were collected 
from all participants to assess serum calcium, phosphorus, parathyroid 
hormone, magnesium, vitamin D, serum albumin, creatinine random urine. 
Results 
Of 40 epileptic children, 23 (57.5%) and 17 (42.5%) were male and female 
res,pectively. The prevalence of lower mean vitamin D levels vitamin D 
was 37.5% for patients compared to 12.5% for controls (chi-square=6.667 
and P=0.010). Of 80 participants, 15 individuals had abnormal PTH levels 
detected of 2 and 13 for patients and control groups, respectively (chi-
square =9.928 and P=0.002). Serum calcium and magnesium levels were 
comparable in both groups. The status of the parameters in the classification 
of normal and abnormal assessed based on number of medications intake 
resulted that number of medications intake had no effect on the status of 
the parameter. 
Conclusion
The frequency of hyperparathyroidism and vitamin D deficiency is 
increased in epileptic children.
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of vitamin D, secondary hyperparathyroidism, 
direct inhibition of intestinal absorption of calcium, 
changes in the metabolism of vitamin K, reducing 
in calcitonin, motility, calcium, and exposure to 
sunlight, and production of endogenous estrogen 
(13). We studied the relationship between bone 
metabolic disorders in children with epilepsy who 
were under long-term treatment and antiepileptic 
drugs (AEDs).
Materials & Methods
This case-control study was conducted on 80 children 
with epilepsy diseases aged from 5 to 15 yr of which 
40 were patients and 40 were controls to assess bone 
metabolism disorders. Sampling was random and 
easy access from those referred to the Pediatric Ward 
and clinics of Ali Ebn Abi Talib Hospital and Ali 
Asghar clinic in Zahedan City, Sistan & Baluchestan 
Province, Iran from Jul 2014 to Jun 2015. 
The sample size of 80 was estimated based on P1= 
0.6%, P2=22% and Z 1-α/2 = 1.96 with the desired 
precision of 5%, alpha of 0.05 (CI of 95%) and 80% 
of power. Sampling method for patients and controls 
was accessible means that referred patients to clinics 
or admitted to the pediatric ward entered to the case 
group. Patients with exclusion criteria were excluded 
from the study. In addition, from those who were not 
taking antiepileptic drugs, 40 selected for the control 
group randomly. The control group participants were 
without any underline diseases and matched with 
patients based on age and sex. 
Both case and control participants were in the 
normal range of weight, height, and growth. Blood 
samples were collected from all participants to 
assess the serum levels of calcium, phosphorus, 
PTH, magnesium, vitamin D, albumin and urine 
calcium and creatinine in random urine sample. 
Since these paraclinical tests are part of routine 
checkup for patients with epilepsy every six months, 
Introduction
Epilepsy is one of major public health problems 
affecting nearly 50 million people worldwide. It is 
one of the most common and long-term neurological 
disorders with a prevalence of 4-10/1000 in 
developed countries. The prevalence is much higher 
in children and aged population (1-3). Epilepsy is 
defined more than two days epileptic seizure without 
any specific causes more than 24 h. 
Patients with epilepsy are required long-term 
treatments and estimated that 1% of populations are 
taking medicine for epilepsy. Due to the long duration 
of treatment, these patients are at risk of side effects. 
Metabolic bone diseases and increased risk of 
fracture are the most important side effects for these 
patients. The relationship between antiepileptic drugs 
(AEDs) and the incidence of rickets, osteomalacia 
and increased fracture is reported (4, 5). The above-
mentioned clinical or subclinical abnormalities 
are observed in 50% or more patients treated with 
antiepileptic drugs (6). Bone disorders due to 
antiepileptic drugs are affected by both duration and 
dose of these medicines and mostly are observed 
bone disorders with all antiepileptic medications 
except gabapentin for instance (7). Antiepileptic 
drugs (AEDs) are along with osteoporosis, other bone 
metabolism disorders and mineral materials such as 
hypocalcemia (8), hypophosphatemia (9), a decrease 
in the serum levels of vitamin D (10) and secondary 
hyperparathyroidism (11, 12). These biochemical 
changes are causes of being at decreasing bone 
density risk, osteoporosis and fracture for patients 
under medication (12). In addition, of mentioned 
factors along with drugs consumption reducing an 
amount of activities, sunlight exposure, vitamin D, 
and calcium have a strong role in bone disorders.
Bone disorders pathogenesis is multifactorial in these 
patients and including changes in the metabolism 
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the researcher did not pay cost for but for controls, 
they did. 
Ethics Committees of Zahedan University of Medical 
Sciences approved the study for MD thesis coded of 
1515.  All parents, caregivers, or legal representatives 
gave informed consent form before participating in 
the study. 
All statistical analyses were performed using SPSS 
software, version 13.0 (Chicago, IL, USA). Age, weight, 
BMI, AED, and levels of calcium were expressed as 
the mean ± standard deviation (SD) and frequency 
(percentage). Comparisons of the frequency distribution 
were conducted by chi-square test. A P-value <0.05 was 
considered statistically significant.
Results
characteristics cases and controls are presented in 
(Table 1). Between two groups of participants, the 
frequency of sex distribution was similar (P> 0.05). 
Mean age of participants was 7.95 ± 2.14 with the 
range of 5-15 years old. Patients had mean age of 
8.17± 2.38 years old with maximum age of 13 years 
old and a minimum age of 5 years old. In healthy 
subjects, mean age was 7.73±1.88 years old with 
maximum age of 12 years old and a minimum age 
of 5 years old. Means of age between healthy people 
and people with seizure did not show any different. 
Table 1. Sex distribution of study subjects in case and control
 Sex
     Control        Case        Total
 n %  n %  n % 
Boys 23 57.5 20 50 43 53.75
Girls 17 42.5 20 50 37 46.25
Total 40 100 40 100 80 100
The prevalence oflower mean D was 37.5% in 
patients compared to 12.5% in controls. (Chi-
square=6.667 and P=0.010). From 80 participants, 
15 individuals had abnormal PHT level distributed 
of 2(5%) and 13(32.50%) for control and case 
participants, respectively (chi-square=9.928 and P= 
0.002) (Table 2).serum calcium and magnesium levels 
were comparable in both groups.All participants had 
normal serum levels of phosphate in both groups 
levels in both case and controls (Table 2). The status 
of the parameters in the classification of normal and 
abnormal assessed based on number of medicines 
intake. In all mentioned parameters, the number of 
medicines intake had no effect on the status of the 
parameter of normality in patients (Table 3). 
20
Bone Metabolism Disorder in Epileptic Children
Table 2. The the frequency of serum parameters levels in two groups of vitamin D, calcium, phosphorus, 
albumin, magnesium hyper parathyroid groups
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Table 3. Chi-square test results to evaluate the effect of the drug on laboratory data only in patients
Varibles  Status
  No of medications 
consumption Total Chi- square P-value
1 2 3
Vitamin D
Abnormal 4 7 4 15 
1.068 0.586Normal 10 11 4 25
Total 14 18 8 40 
Parathyroid
Abnormal 2 7 4 13
 3.569  0.168Normal 12 11 4 27
Total 14 18 8 40 
Calcium
Abnormal 1 1 1 3
 0.389     0.823Normal 13 17 7 37
Total 14 18 8 40
 Magnesium
Abnormal 1 0 0 1
 1.905 0.386Normal 13 18 8 39
Total 14 18 8 40
 Phosphate
Abnormal 0 0 0 0
  -    -Normal 14 18 8 40
Total 14 18 8 40
 Albumin
Abnormal 0 0 0 0
   -    -Normal 14 18 8 40
Total 14 18 8 40
Discussion
Calcium and vitamin D play important roles in bone 
metabolism and preserving adequate bone mass. This 
study was performed on 80 children, of which 40 
were taking antiepileptic drugs more than 6 months 
and 40 were healthy. Two groups were matched in 
age and sex.
Normal status of vitamin D has remarkable influence 
in children and adolescent who are growing. Our 
analysis showed that in the level of abnormality, 
PTH and the level of serum calcium were higher in 
patients compared to controls. 
Several factors have important role in calcium 
metabolism and bone disorder such as dark skin, 
contacts and lack of sufficient additional sunlight and 
supplementary vitamin D intake (14).
The effects of antiepileptic medicines on various 
exogenous and endogenous substances have been 
investigated. Some of antiepileptic drugs AEDs can 
cause vitamin D deficiency by influencing hepatic 
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P450 system in the liver or disrupt 25-hydroxylation 
liver.
Some antiepileptic drugs may have an association 
with metabolism and bone mineral cycles due to the 
effects on bone cells (osteoblasts and osteoclasts) 
(15, 16). Our study showed that the prevalence of 
vitamin D deficiency and hypoparathyroidism was 
higher in patients. In a study that performed on 33 
patients treated with antiepileptic drugs, 36% had 
insufficient levels of vitamin D deficiency and 58% 
had low level (17). Another study conducted on 38 
children who received antiepileptic drugs and 44 
healthy,  75%  of patients had vitamin D deficiency, 
and 21% had insufficient vitamin D levels and the 
amounts of PTH were different between patients and 
controls (18). Another study conducted on effects of 
anti-epileptic drugs on bone metabolism. The levels 
of serum calcium and serum phosphate were normal 
in 93.76%, 93.3% of patients’, respectively.  The 
Alkaline phosphates levels was in the normal and 
higher than normal in 76.5% and 23.5% of patients 
respectively. The PTH levels were in the normal 
and higher than normal in 77.3% and 18.5% of 
patients , respectively Increasing the level of alkaline 
phosphatase and PTH was significantly higher 
in patients than the control group (19). A similar 
study was conducted with the aims of assessing the 
effects of anticonvulsants on vitamin D metabolism 
in children with epilepsy, which 89 children with 
epilepsy and taking antiepileptic drugs for at least six 
months without underlying disease were included. 
About 42% of patients had vitamin D deficiency. 
Serum calcium and phosphate levels were in the 
normal range. Vitamin D levels were not statistically 
significant in some factors such as age group, sex, 
type of medicines for the treatment, therapy or 
Monotherapy Bridge and resistance to treatment (20). 
Similar to our results, in another study, the levels of 
vitamin D did not show differences accordance with 
the variables of age, sex, type of medication for the 
treatment, therapy or Monotherapy Bridge and of 111 
patients, 22% were in the deficient level of vitamin D 
and 41% had insufficient vitamin D (21). The results 
of this study were similar to our results.
In Conclusion, the frequency of hyperparathyroidism 
and vitamin D deficiency was higher in epileptic 
children. Supplemental vitamin-D administration in 
such patients may be helpful. Measuring calcium and 
vitamin D levels are essential in epileptic patients, 
especially when remembering that they are at higher 
risk of falling and bone fractures.
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